首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current medical research and opinion

缩写:CURR MED RES OPIN

ISSN:0300-7995

e-ISSN:1473-4877

IF/分区:2.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引5080
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Philip J Mease,Taylor Blachley,William N Malatestinic et al. Philip J Mease et al.
Objective: To describe bDMARD initiators by biologic experience among ankylosing spondylitis (AS) patients and change in disease activity and patient-reported outcomes (PROs) in real-world US patients. ...
Oscar Herrera-Restrepo,Zifan Zhou,Annie Krishnan et al. Oscar Herrera-Restrepo et al.
Objective: Meningococcal serogroup B (MenB) vaccination is recommended by the Advisory Committee on Immunization Practices (ACIP) for adolescents and young adults 16-23-years-old under shared clinical decision-making (SCD...
Rui Cui,BeiYao Gao,RuiDong Ge et al. Rui Cui et al.
Background: Studies demonstrate that people who have been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, have experienced cognitive dysfunction, including workin...
Feifei Lu,Siqi Jia,Huiyuan Lu et al. Feifei Lu et al.
Budd-Chiari syndrome (BCS) and sinusoidal obstruction syndrome (SOS) are two major vascular disorders of the liver, of which both can cause portal hypertension related complications, but their locations of obstruction are different. BCS ref...
Bilal Katipoglu,Seda Kurtbeyoglu,Zeliha Asli Demir et al. Bilal Katipoglu et al.
Objective: The cumulative effect of drugs with anticholinergic properties may pose a significant risk in the post-discharge period of patients who have undergone elective cardiac surgery. The aim of this study was to inve...
Bernhard T Baune Bernhard T Baune
Most patients with schizophrenia need life-long treatment. There is therefore a continued need for effective and tolerable treatment options. A 2-monthly LAI formulation of aripiprazole, Aripiprazole 2-Month Ready-to-Use 960 mg (Ari 2MRTU 9...